Rivaroxaban vs warfarin for mechanical heart valves
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares a newer blood thinner (rivaroxaban) to the standard one (warfarin) for people with mechanical heart valves who have had clots or bleeding while on warfarin, or who cannot easily monitor their INR levels. It aims to see if rivaroxaban is safer and more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a mechanical heart valve and are an adult 18 or older.
- You have had a blood clot or bleeding problem while taking warfarin, or you have limited access to INR testing.
- You are willing and able to give informed consent.
- You have not had a hemorrhagic or ischemic stroke in the last 3 months.
- You do not have severe kidney disease (creatinine clearance below 30 mL/min).
- You do not have a condition that raises your risk of bleeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares a blood thinner pill (a factor Xa inhibitor) with warfarin (vitamin K antagonist) in people who have had a mechanical aortic valve replacement. It looks at which option works better and is safer over the long term.
This trial tests a blood thinner called rivaroxaban (Xarelto) given right after heart valve surgery with a tissue valve. It aims to see if it can prevent blood clots or strokes safely in the early recovery period.
This trial tests two doses of rivaroxaban (15mg and 20mg) to see how well they prevent strokes in people with non-valvular atrial fibrillation, a type of irregular heartbeat not caused by a heart valve problem. It may be an option if you need blood thinners to lower your stroke risk.
This study compares two commonly used blood thinners (apixaban and rivaroxaban) to see which works better for people with non-valvular atrial fibrillation, a type of irregular heartbeat. The goal is to find the safest and most effective option for preventing strokes.
This study tests different ways to use blood thinners after a minimally invasive heart valve repair procedure. It may help patients who need long-term blood thinning to prevent clots or stroke.
This trial tests if a full dose of rivaroxaban (a blood thinner) works better than a lower preventive dose for treating a superficial vein clot in the leg. It aims to find the safest and most effective way to stop the clot from getting worse or causing a more serious clot.
Hear when a new Valvular Heart Disease Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.